BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27750143)

  • 1. Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens.
    Soggiu A; Piras C; Greco V; Devoto P; Urbani A; Calzetta L; Bortolato M; Roncada P
    Psychoneuroendocrinology; 2016 Dec; 74():387-396. PubMed ID: 27750143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.
    Frau R; Abbiati F; Bini V; Casti A; Caruso D; Devoto P; Bortolato M
    Schizophr Res; 2015 Nov; 168(3):640-8. PubMed ID: 25999042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.
    Devoto P; Frau R; Bini V; Pillolla G; Saba P; Flore G; Corona M; Marrosu F; Bortolato M
    Psychoneuroendocrinology; 2012 Oct; 37(10):1630-45. PubMed ID: 22029952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli.
    Godar SC; Cadeddu R; Floris G; Mosher LJ; Mi Z; Jarmolowicz DP; Scheggi S; Walf AA; Koonce CJ; Frye CA; Muma NA; Bortolato M
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31752360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments.
    Bortolato M; Devoto P; Roncada P; Frau R; Flore G; Saba P; Pistritto G; Soggiu A; Pisanu S; Zappala A; Ristaldi MS; Tattoli M; Cuomo V; Marrosu F; Barbaccia ML
    Neuropharmacology; 2011 Jun; 60(7-8):1301-8. PubMed ID: 21256141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting.
    Floris G; Scheggi S; Pes R; Bortolato M
    Brain Res Bull; 2022 Apr; 181():157-166. PubMed ID: 35122898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.
    Frau R; Bini V; Soggiu A; Scheggi S; Pardu A; Fanni S; Roncada P; Puligheddu M; Marrosu F; Caruso D; Devoto P; Bortolato M
    Neuropsychopharmacology; 2017 Oct; 42(11):2196-2205. PubMed ID: 28102229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain.
    Giatti S; Foglio B; Romano S; Pesaresi M; Panzica G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroendocrinology; 2016; 103(6):746-57. PubMed ID: 26646518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal finasteride administration decreases dopamine release in nucleus accumbens after alcohol and food presentation in adult male rats.
    Llidó A; Bartolomé I; Darbra S; Pallarès M
    Behav Brain Res; 2016 Aug; 309():44-50. PubMed ID: 27139934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.
    Paba S; Frau R; Godar SC; Devoto P; Marrosu F; Bortolato M
    Curr Pharm Des; 2011; 17(2):151-67. PubMed ID: 21361868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition.
    Diviccaro S; Giatti S; Borgo F; Barcella M; Borghi E; Trejo JL; Garcia-Segura LM; Melcangi RC
    Psychoneuroendocrinology; 2019 Jan; 99():206-215. PubMed ID: 30265917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5α-dihydrotestosterone in testicular development of gilthead seabream following finasteride administration.
    García-García M; Sánchez-Hernández M; García-Hernández MP; García-Ayala A; Chaves-Pozo E
    J Steroid Biochem Mol Biol; 2017 Nov; 174():48-55. PubMed ID: 28739284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated finasteride administration induces depression-like behavior in adult male rats.
    Sasibhushana RB; Shankaranarayana Rao BS; Srikumar BN
    Behav Brain Res; 2019 Jun; 365():185-189. PubMed ID: 30836157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of Finasteride on Mean and Relative Spectral Density of EEG Bands in Rat Model of Thioacetamide-Induced Hepatic Encephalopathy.
    Mladenović D; Hrnčić D; Rašić-Marković A; Macut Dj; Stanojlović O
    Neurotox Res; 2016 Aug; 30(2):150-8. PubMed ID: 26951455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bioactivity of new Finasteride conjugate.
    Shuang Z; Jiazhen W; Lijuan Y; Zhuo L; Dahai Y; Jinfeng L; Jing Y; Yongtao L; En-Si W; Xuexun F
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3439-42. PubMed ID: 21515045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-like properties of 5-alpha-reductase inhibitors.
    Bortolato M; Frau R; Orrù M; Bourov Y; Marrosu F; Mereu G; Devoto P; Gessa GL
    Neuropsychopharmacology; 2008 Dec; 33(13):3146-56. PubMed ID: 18354385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Frau R; Savoia P; Fanni S; Fiorentini C; Fidalgo C; Tronci E; Stancampiano R; Meloni M; Cannas A; Marrosu F; Bortolato M; Devoto P; Missale C; Carta M
    Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.